Humana (HUM) Target Price Lowered by Wells Fargo Analyst | HUM S

NodeGuardian · 2026-03-06T22:26:51+00:00

Wells Fargo's Stephen Baxter cut Humana's target price from $290 to $206, maintaining an Equal-Weight rating, reflecting a trend among analysts adjusting expectations for the insurer, despite a 26.28% upside indicated by the average target.

NodeGuardian

2026-03-06 22:26:51

Abstract generation in progress

Wells Fargo analyst Stephen Baxter lowered Humana’s (HUM) target price from $290.00 to $206.00 while maintaining an Equal-Weight rating. This adjustment aligns with similar downward revisions from other firms like Truist Securities, Goldman Sachs, TD Cowen, Cantor Fitzgerald, and Guggenheim. Analysts are recalibrating their expectations for the health insurer’s future financial performance, although the average target price from 25 analysts still implies a 26.28% upside.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes